The size of the Europe Safety Syringes Market was worth USD 1.53 Billion in 2021. It is further predicted to reach USD 2.25 Billion by 2026, growing at a CAGR of 7.97% from 2021 to 2026.
Injections are one of the most common health-care procedures. Every year at least 16 billion injections are administered worldwide. The vast majority – around 90% – are given in curative care. Immunization injections account for around 5% of all injections.
With the ever-rising demand to protect healthcare professionals from accidental needle-stick injuries and hospital-acquired infections, there has been an upsurge in demand for safety syringes. Further, rising occurrences of needlestick injuries, government initiatives, and legislation to integrate the practice of safety syringes, improved safety mechanisms for syringes, and favorable reimbursement policies support the growth of the Safety Syringes market in European countries. Presently, several countries have enforced regulations to ensure the compulsory use of safety syringes to prevent needlestick injuries and restrict needle re-use.
However, accessibility to alternate drug delivery methods, expensiveness of safety syringes, ignorance in low-income regions due to unawareness about healthcare, and safety issues are few factors preventing the steady growth of the European safety syringes market.
This research report on the European Safety Syringes Market has been segmented and sub-segmented into the following categories:
By Technology:
By Therapy:
By End Users:
By Country:
Regionally, European countries together hold the second position in terms of revenue and volume in the global safety syringes market. The United Kingdom represents the largest share of the European safety syringes market, followed by Germany. At the same time, Spain is expected to record the highest CAGR within the forecast period. Further, the growing demand for prefilled syringes fortified with safety features in this region is also adding to the market growth.
Key market players in the European Safety Syringes Market profiled in this report are Covidien plc, Retractable Technologies Inc., Becton, Dickinson & Company, Terumo Corporation, Unilife Revolutions Medical Corporation, Smiths Medical, Sol-Millennium, Ultimed Inc., and Axel Bio Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Technology
5.1.1 Retractable safety syringes
5.1.1.1 Automatic retractable safety syringes
5.1.1.2 Manual retractable safety syringes
5.1.2 Non-Retractable safety syringes
5.1.2.1 Sheathing tube syringes
5.1.2.2 Sliding needle cover syringes
5.1.2.3 Hinged needle cover syringes
5.2 By Therapy
5.2.1 Insulin
5.2.2 Glucagon-like peptide-1 (glp-1)
5.2.3 Tuberculosis
5.2.4 Growth hormones
5.3 By End User
5.3.1 Hospitals
5.3.2 Home Care
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Becton, Dickinson & Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Covidien plc
8.3 Revolutions Medical Corporation
8.4 Retractable Technologies, Inc.
8.5 Smiths Medical
8.6 Unilife Corporation
8.7 Terumo Corporation
8.8 Sol-Millennum
8.9 Ultimed, Inc.
8.10 Axel Bio Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
